
The cross-Atlantic partnership CARB-X, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, has announced that it would be funding 11 biotech companies …
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ

